AzTrials
AzTrials

Death AnxietyNCT07774468

Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses

A study testing Death Conversation and Online ACP Education in people with Death Anxiety and Death Attitude (Implicit/Explicit), run by National University of Singapore at 1 site in Singapore.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate whether the PEACE program can improve early career registered nurses' registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death, and self-efficacy in initiating advanced care planning conversations This study aims to address… Read more about this study

Who is it for?
Ages 21 to 65 yearsHealthy volunteers can take part
What is being tested?
Death Conversation and Online ACP Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteSingapore
Study dates
1 Sep 2026to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Registered nurses within the first five years of practice
  • Between the ages of 21 to 65 years
  • Currently working in a healthcare setting in SIngapore

Who cannot join

  • Participated in a similar death conversation program
  • Received training in Advance Care Planning or Serious Illness Conversations
  • Any self-reported history of mental health disorders (e.g., depression), or neurological disorders (e.g., brain tumors)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Darryl Ang, PhD contact

+65 65167792

darrylang@nus.edu.sg

Singapore1 site
  • National University of Singapore

    Singapore

    Darryl Ang, PhD, +65 65167792, darrylang@nus.edu.sg

Other trials in Singapore

About this study

Official title: Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses: A Mixed Methods Study

The goal of this clinical trial is to evaluate whether the PEACE program can improve early career registered nurses' registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death, and self-efficacy in initiating advanced care planning conversations

This study aims to address the following research questions:

Read more
  • Does the PEACE program improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations?
  • What are the participants' experiences of participating in the PEACE program?

Researchers will compare participants who receive the PEACE program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.

Participants will:

  • Complete online questionnaires measuring attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.
  • Participate in a facilitator-led group discussion session about experiences of patients' deaths, coping with patients' death and dying, communications with patients and/or family members about death and dying, and discussing advance care planning with patients and/or family members (intervention group only).
  • Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
  • Complete follow-up surveys, including a 3-month follow-up assessing whether participants have engage with any patients and/or their family members in advance care planning conversations.
Being tested
Death Conversation, Online ACP Education
Keywords
Death Conversation, Death Anxiety, Advance Care Planning, Death Attitude
Medical subject headings
Necrophobia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Death ConversationBehavioural

    On site, facilitator-led group discussion lasting 2 hours, covering: 1) Experiences of patients' deaths; 2) Coping with patients' death and dying; 3) Communication with patients and/or family members about death and dying; 4) Discussing advance care planning with patients and/or family members

  • Online ACP EducationBehavioural

    An online asynchronous learning session with short videos on ACP with discussion forums.

Study groups in NCT07774468
Study groupRoleWhat they receive
Intervention Group - on site group discussions + online learning sessionExperimentalParticipants in this arm will receive the two-session PEACE Program. Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering: 1. Experiences of death and dying 2. Coping with death and dying. 3. Communication about death and dying 4. Discussing Advance Care Planning (ACP). Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums.
Receives: Behavioral: Death Conversation; Behavioral: Online ACP Education
Control Group - Only online learning sessionActive comparatorParticipants in this arm will only receive the online ACP education component, identical to Session 2 of the PEACE programme. No facilitator-led group discussions are provided.
Receives: Behavioral: Online ACP Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Advance Care Planning Self-Efficacy (ACP-SE) Scale

    An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.

    Measured: Baseline

  2. Advance Care Planning Self-Efficacy (ACP-SE) Scale

    An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.

    Measured: Post-test (Immediately at end of 2-weeks intervention)

  3. Advance Care Planning Self-Efficacy (ACP-SE) Scale

    An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.

    Measured: 3 months follow-up

Secondary outcomes (7)
  1. Palliative care self-efficacy scale

    A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.

    Measured: Baseline

  2. Palliative care self-efficacy scale

    A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.

    Measured: Post-test (Immediately at end of 2-weeks intervention)

  3. Palliative care self-efficacy scale

    A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.

    Measured: 3 months follow-up

  4. Frommelt Attitude Toward Care of the Dying Scale

    A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.

    Measured: Baseline

  5. Frommelt Attitude Toward Care of the Dying Scale

    A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.

    Measured: Post-test (Immediately at end of 2-weeks intervention)

  6. Frommelt Attitude Toward Care of the Dying Scale

    A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.

    Measured: 3 months follow-up

  7. End-of-life planning conversations

    Self-reported number of conversations held with patients regarding Advance Care Planning

    Measured: 3 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07774468
Sponsor's protocol ID
NUS-DERC-001647
Other IDs
A-0010425-00-00
Status last verified
Aug 2026
First submitted
11 Aug 2026
Last updated
28 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Death Conversation and Online ACP Education in people with Death Anxiety and Death Attitude (Implicit/Explicit), run by National University of Singapore at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Darryl Ang, PhD (+65 65167792, darrylang@nus.edu.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Advance Care Planning Self-Efficacy (ACP-SE) Scale (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in